Masahiro Takeshima
Overview
Explore the profile of Masahiro Takeshima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
319
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Komatsu M, Takeshima M, Yoshizawa K, Ogasawara M, Kudo M, Miyakoshi E, et al.
Front Psychiatry
. 2024 Dec;
15:1471457.
PMID: 39717375
Introduction: Hypnotic polypharmacy and its long-term prescriptions constitute the inappropriate use of hypnotics. However, the relationship between hypnotic polypharmacy and prolonged prescriptions remains unclear. This study aimed to elucidate the...
2.
Irinaka K, Itoh Y, Yoshizawa K, Ogasawara M, Ayabe N, Mishima K, et al.
Clin Psychopharmacol Neurosci
. 2024 Oct;
22(4):688-696.
PMID: 39420617
Tardive dyskinesia and dystonia are intractable extrapyramidal symptoms caused by the blockade of dopamine receptors by antipsychotic drugs. In addition to the reduction or discontinuation of the causative drug, valbenazine...
3.
Matsui K, Utsumi T, Aoki Y, Maruki T, Takeshima M, Takaesu Y
J Med Internet Res
. 2024 Aug;
26:e52758.
PMID: 39151163
Background: The screening process for systematic reviews is resource-intensive. Although previous machine learning solutions have reported reductions in workload, they risked excluding relevant papers. Objective: We evaluated the performance of...
4.
Takeshima M, Yoshizawa K, Ogasawara M, Kudo M, Itoh Y, Ayabe N, et al.
Front Psychiatry
. 2024 Jul;
15:1405049.
PMID: 39026522
Introduction: Guidelines for various psychiatric disorders recommend short-term use of benzodiazepine anxiolytic monotherapy in few cases. Contrarily, benzodiazepine anxiolytic polypharmacy (BAP) is not recommended in any case. However, BAP is...
5.
Takeshima M, Yoshizawa K, Ogasawara M, Kudo M, Itoh Y, Ayabe N, et al.
Psychogeriatrics
. 2024 Jul;
24(5):1176-1179.
PMID: 39010736
No abstract available.
6.
Takeshima M, Sakurai H, Inada K, Aoki Y, Ie K, Kise M, et al.
BMC Prim Care
. 2024 Jun;
25(1):219.
PMID: 38890610
Background: It is unclear how primary care physicians manage insomnia after the introduction of novel hypnotics such as orexin receptor antagonists and melatonin receptor agonists. This Web-based questionnaire survey aimed...
7.
Association between sleep state misperception and bedtime behavior in patients with chronic insomnia
Kudo M, Ayabe N, Takeshima M, Ogasawara M, Itoh Y, Yoshizawa K, et al.
Sci Rep
. 2024 Jun;
14(1):13991.
PMID: 38886489
Previous studies on sleep state misperception have objectively evaluated sleep status in special environments using polysomnography. There is a paucity of data from studies that evaluated habitual sleep status in...
8.
Sakurai H, Takeshima M, Inada K, Aoki Y, Ie K, Kise M, et al.
PCN Rep
. 2024 Jun;
2(3):e118.
PMID: 38867823
Aim: Clinicians face difficulties in making treatment decisions for unspecified anxiety disorder due to the absence of any treatment guidelines. The objective of this study was to investigate how familiar...
9.
Nakamura T, Furihata R, Hasegawa N, Kodaka F, Muraoka H, Ichihashi K, et al.
BMC Psychiatry
. 2024 May;
24(1):399.
PMID: 38807065
Background: To examine whether the "Effectiveness of Guideline for Dissemination and Education in psychiatric treatment (EGIUDE)" project affects the rate of prescriptions of hypnotic medication and the type of hypnotic...
10.
Takeshima M, Yoshizawa K, Ogasawara M, Kudo M, Itoh Y, Ayabe N, et al.
JAMA Netw Open
. 2024 Apr;
7(4):e246865.
PMID: 38630476
Importance: Although insomnia guidelines recommend the use of several individual hypnotics, the most useful hypnotic for treating insomnia in a clinical setting remains unclear. Objective: To determine which guideline-recommended hypnotics...